Dr. Reddy's Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	346,321	325,535	279,164	245,879	214,391	189,722
Revenue Growth (YoY)	18.70%	16.61%	13.54%	14.69%	13.00%	-
Cost of Revenue	136,169	135,107	115,557	106,536	100,551	86,645
Gross Profit	210,152	190,428	163,607	139,343	113,840	103,077
Selling, General & Admin	81,974	93,870	77,201	68,026	62,081	54,650
Depreciation & Amortization Expenses	19,564	-	-	-	-	-
Research & Development	12,446	27,380	22,873	19,381	17,482	16,541
Other Operating Expenses	41,870	-2,665	-4,196	-5,208	4,801	7,606
Total Operating Expenses	155,854	118,585	95,878	82,199	84,364	78,797
Operating Income	64,105	71,843	67,729	57,144	29,476	24,280
Interest Income	4,081	7,553	5,705	4,281	3,077	2,623
Interest Expense	-3,337	-2,829	-1,711	-1,428	-958	-970
Other Non-Operating Income (Expense)	8,052	217	147	370	703	480
Total Non-Operating Income (Expense)	8,796	4,941	4,141	3,223	2,822	2,133
Pretax Income	72,881	76,784	71,870	60,367	32,298	26,413
Provision for Income Taxes	16,754	19,539	16,186	15,300	8,730	9,175
Net Income	56,582	56,544	55,684	45,067	23,568	17,238
Minority Interest in Earnings	-455	701	-	-	-	-
Net Income to Common	56,582	56,544	55,684	45,067	23,568	17,238
Net Income Growth	11.04%	1.54%	23.56%	91.22%	36.72%	-
Shares Outstanding (Basic)	724	833	832	830	829	829
Shares Outstanding (Diluted)	725	834	834	832	832	832
Shares Change (YoY)	-5.19%	0.08%	0.19%	0.03%	0.01%	-
EPS (Basic)	86.50	67.89	67.04	54.28	28.42	20.79
EPS (Diluted)	86.41	67.79	66.92	54.17	28.34	20.73
EPS Growth	25.94%	1.30%	23.54%	91.16%	36.70%	-
Shares Outstanding	832.57	832	832.64	830.78	829.79	828.63
Free Cash Flow	36,656	18,924	29,030	47,552	13,448	25,962
Free Cash Flow Growth	93.70%	-34.81%	-38.95%	253.60%	-48.20%	-
Free Cash Flow Per Share	50.57	22.69	34.83	57.16	16.17	31.22
Dividends Per Share	8.000	8.000	8.000	8.000	6.000	5.000
Dividend Growth	-	-	-	33.33%	20.00%	-
Gross Margin	60.68%	58.50%	58.61%	56.67%	53.10%	54.33%
Operating Margin	18.51%	22.07%	24.26%	23.24%	13.75%	12.80%
Profit Margin	16.21%	17.58%	19.95%	18.33%	10.99%	9.09%
FCF Margin	10.58%	5.81%	10.40%	19.34%	6.27%	13.68%
EBITDA	83,688	88,901	82,429	69,780	41,300	37,076
EBITDA Margin	24.16%	27.31%	29.53%	28.38%	19.26%	19.54%
EBIT	64,105	71,843	67,729	57,144	29,476	24,280
EBIT Margin	18.51%	22.07%	24.26%	23.24%	13.75%	12.80%
Effective Tax Rate	22.99%	25.45%	22.52%	25.35%	27.03%	34.74%

Updated Jan 22, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q